Drugs HIV Prevention

Regulatory agency the U.S. Food and Drug Administration (FDA) on Monday approved Truvada, the first drug to be legalized to reduce the risk of HIV infection in people who are infected but have no risk of the virus because of sexual contact with an infected partner.

The daily pill-shaped drug made ​​by Gilead Sciences in California company, combining the two drugs that block HIV reproduction.

The use of the drug should be coupled with safe sex to reduce the risk of infection.

“Truvada should not be used to prevent HIV infection by itself,” said FDA official Dr. Debra Birnkrant during a press conference.

FDA previously approved Truvada for use with other antiretroviral drugs for the treatment of adults and children over 12 years who are infected with HIV.

The FDA said people who take Truvada should undergo tests to detect HIV infections every three months so that treatment can be started if an infection occurs.

“Permission marks an important step in our war against HIV,” said FDA Commissioner Margaret scattering in a statement.

“Every year, some 50,000 adults and adolescents diagnosed with HIV infection …. This type of new treatments and prevention methods are needed to combat the HIV epidemic in this country,” he said.

Pos ini dipublikasikan di Tak Berkategori. Tandai permalink.

Tinggalkan Balasan

Isikan data di bawah atau klik salah satu ikon untuk log in:

Logo WordPress.com

You are commenting using your WordPress.com account. Logout / Ubah )

Gambar Twitter

You are commenting using your Twitter account. Logout / Ubah )

Foto Facebook

You are commenting using your Facebook account. Logout / Ubah )

Foto Google+

You are commenting using your Google+ account. Logout / Ubah )

Connecting to %s